Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for producing in vitro the RNA-dependent RNA polymerase and terminal nucleotidyl transferase activities encoded by hepatitis C virus (HCV)

Method for producing in vitro the RNA-dependent RNA polymerase and terminal nucleotidyl transferase activities encoded by hepatitis C virus (HCV)

US Patent 6383768 · Granted May 7, 2002

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Optimized host/vector system for producing protective mono-and multivalent subun2025
Oxalamido-substituted tricyclic inhibitors of hepatitis b virus2025
Spirocyclic inhibitors of hepatitis B virus2025
Optimized host/vector system for producing protective mono- and multivalent subu2024
Tricyclic inhibitors of Hepatitis B virus2022
Vaccination by means of recombinant yeast by producing a protective humoral immu2021
Small antibody-like polypeptides that bind to EPHA2 receptor2020
Method for the oral/mucosal vaccination by means of recombinant yeasts2018
Replication stable and RNase resistant chimeras of pestivirus with insertion in 2015
Chimeric pestivirus with insertion in 3′ nontranslated region (3′NTR) with stabl2015
Hepatitis c virus replicons and replicon enhanced cells2012
Method for identifying a HCV RNA-dependent RNA polymerase inhibitor2008